期刊文献+

甲氧氯普胺口崩片的制备及体外溶出度考察

Preparation and in vitro Release of Metoclopramide Orally Disintegrating Tablets
在线阅读 下载PDF
导出
摘要 目的:制备甲氧氯普胺口崩片并优化处方,并对其体外溶出度进行考察。方法:采用全因子试验设计,以填充剂配比(X1)、崩解剂(X2,%)用量为影响因素,以脆碎度(Y1,%)、崩解时限(Y2,s)、甲氧氯普胺在15 min的溶出度(Y3,%)为片剂考察指标优化处方;并考察其在4种溶出介质中的溶出行为。结果:甲氧氯普胺口崩片的最优处方组成为:填充剂甘露醇与微晶纤维素比例为2.5∶1、崩解剂占片重为6.5%。甲氧氯普胺口崩片在4种溶出介质中累积溶出度均大于80%。结论:甲氧氯普胺口崩片处方设计合理,制备工艺可行,质量可控。 Objective:To prepare and optimize the formula of metoclopramide orally disintegrating tablets, and investigate the in vitro drug dissolution behavior. Methods:The formula was optimized by full-factorial experiment design, the ratio of mannotil to micro-crystalline cellulose ( X1 ) and the amount of disintegrating agent ( X2 ,%) were selected as the independent variables, and the friabili-ty ( Y1 ,%) , disintegration time ( Y2 , s) and metoclopramide dissolution ( Y3 ,%) were used as the dependent variables. The release rate of metoclopramide orally disintegrating tablets in different dissolution media was studied. Results:The optimum formula of meto-clopramide orally disintegrating tablets was as follows:the ratio of mannotil to microcrystalline cellulose was 2. 5∶ 1, and the amount of disintegrating agent was 6. 5%. The dissolution of metoclopramide orally disintegrating tablets in the different dissolution media was o-ver 80%. Conclusion:The formula design is reasonable, the preparation process is feasible and the quality can be controlled.
出处 《中国药师》 CAS 2015年第11期1882-1884,1894,共4页 China Pharmacist
关键词 甲氧氯普胺 口崩片 全因子试验设计 脆碎度 崩解时限 溶出度 Metoclopramide Orally disintegrating tablets Full-factorial experiment design Friability Disintegration time Dis-solution
  • 相关文献

参考文献8

  • 1Boer TD,Ruit GSF,Berendsen HHG. The selective adrenoceptorantagonist 0i3770 ( mirtazapine,Remeron) enhances noradrenergicand serotoner transmission [J], Hum Psycho- pharmcol, 1995, 10(2):107-118.
  • 2高春生.速释固体制剂的研究进展[J].国外医学(药学分册),1998,25(5):293-298. 被引量:29
  • 3何忠芳,陈岚,王亚娟.口腔速崩片的研究进展及应用前景[J].兰州医学院学报,2003,29(1):89-91. 被引量:19
  • 4Mizumoto T, Masuda Y, Yamamoto Tfetal. Formulation design of anovel fast-disintegrating tablet [J]. Int J Pharm,2005 , 306( 1-2):83-90.
  • 5Husban F, Perrie Y, Mohammed AR. Formulation and characterisationof lyophilised rapid disintegrating tablets using amino acids as matrixforming agents [ J]. Eur J Pharm Biopharm, 75(2) :254-262.
  • 6Fu Y, Jeong SH,Park K. Fast-melting tablets based on highly plasticgranules [ J]. J Control Release, 2005,109( 1-3) , 203-210.
  • 7Shukla D, Chakraborty S,Sin讲 S,et al. Mouth Dissolving Tablets I :An Overview of Formulation Technology [ J ]. Sci Pharm, 2009,77(3),309-326.
  • 8Kuno Y, Kojima M, Ando S,et al. Effect of preparation method onproperties of orally disintegrating tablets made by phase transition [ J].int J Pharm, 2008,355(1-2),87-92.

二级参考文献1

  • 1毕殿洲.药剂学(第4版)[M].北京:人民卫生出版社,1999.56.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部